Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine or Hydroxychloroquine in COVID-19 Treatment
NCT04353336Phase 3Completed
- Sponsor
- Tanta University
- Start
- Mar 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chloroquine, hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Started Mar 2020; status: completed.
02
Drugs
chloroquinehydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04353336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353336.